Novel motif:61
From FANTOM5_SSTAR
name: | motif61_KAYMGMTN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048239 | negative regulation of DNA recombination at telomere | 4.943212e-11 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 1.795117e-10 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.867088e-10 |
GO:0042149 | cellular response to glucose starvation | 6.993073e-10 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.299959e-9 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 3.827210e-9 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 8.604468e-9 |
GO:0031860 | telomeric 3' overhang formation | 2.542775e-8 |
GO:0000183 | chromatin silencing at rDNA | 3.318209e-8 |
GO:0016233 | telomere capping | 4.135236e-8 |
GO:0071243 | cellular response to arsenic-containing substance | 6.278633e-8 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 8.259883e-8 |
GO:0070857 | regulation of bile acid biosynthetic process | 1.458115e-7 |
GO:0003329 | pancreatic PP cell fate commitment | 6.521090e-7 |
GO:0003326 | pancreatic A cell fate commitment | 6.521090e-7 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.256760e-6 |
GO:0046685 | response to arsenic-containing substance | 1.340972e-6 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 1.955997e-6 |
GO:0015780 | nucleotide-sugar transport | 2.464356e-6 |
GO:0006529 | asparagine biosynthetic process | 3.369564e-6 |
GO:0060580 | ventral spinal cord interneuron fate determination | 5.427855e-6 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 5.427855e-6 |
GO:0003327 | type B pancreatic cell fate commitment | 5.427855e-6 |
GO:0046502 | uroporphyrinogen III metabolic process | 7.748355e-6 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.019787e-5 |
GO:0043973 | histone H3-K4 acetylation | 1.019787e-5 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.019787e-5 |
GO:0032972 | regulation of muscle filament sliding speed | 1.019787e-5 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 1.127282e-5 |
GO:0006264 | mitochondrial DNA replication | 1.336623e-5 |
GO:0045329 | carnitine biosynthetic process | 1.621711e-5 |
GO:0071670 | smooth muscle cell chemotaxis | 1.767355e-5 |
GO:0060981 | cell migration involved in coronary angiogenesis | 1.767355e-5 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.767355e-5 |
GO:0009589 | detection of UV | 1.767355e-5 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.963171e-5 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 2.039072e-5 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.286810e-5 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 2.734728e-5 |
GO:0031627 | telomeric loop formation | 3.130668e-5 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 3.364844e-5 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 4.130600e-5 |
GO:0007210 | serotonin receptor signaling pathway | 4.437885e-5 |
GO:0050957 | equilibrioception | 4.732133e-5 |
GO:0006635 | fatty acid beta-oxidation | 5.479415e-5 |
GO:0032042 | mitochondrial DNA metabolic process | 6.558921e-5 |
GO:2000779 | regulation of double-strand break repair | 7.187031e-5 |
GO:0008643 | carbohydrate transport | 7.501020e-5 |
GO:0060242 | contact inhibition | 8.045086e-5 |
GO:0048243 | norepinephrine secretion | 8.148010e-5 |
GO:0060465 | pharynx development | 8.308587e-5 |
GO:0051355 | proprioception involved in equilibrioception | 8.308587e-5 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 8.308587e-5 |
GO:0000076 | DNA replication checkpoint | 8.968082e-5 |
GO:0006528 | asparagine metabolic process | 9.048384e-5 |
GO:0001973 | adenosine receptor signaling pathway | 9.818304e-5 |
GO:0035909 | aorta morphogenesis | 9.919683e-5 |
GO:0043456 | regulation of pentose-phosphate shunt | 1.187538e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.210677e-4 |
GO:0033034 | positive regulation of myeloid cell apoptosis | 1.255442e-4 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 1.487275e-4 |
GO:0006260 | DNA replication | 1.547895e-4 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 1.643567e-4 |
GO:0007004 | telomere maintenance via telomerase | 1.783558e-4 |
GO:0006348 | chromatin silencing at telomere | 1.869815e-4 |
GO:0035090 | maintenance of apical/basal cell polarity | 1.938283e-4 |
GO:0051181 | cofactor transport | 1.971681e-4 |
GO:0006541 | glutamine metabolic process | 2.179700e-4 |
GO:2000481 | positive regulation of cAMP-dependent protein kinase activity | 2.425237e-4 |
GO:2000534 | positive regulation of renal albumin absorption | 2.425237e-4 |
GO:0015742 | alpha-ketoglutarate transport | 2.425237e-4 |
GO:2000478 | positive regulation of metanephric glomerular visceral epithelial cell development | 2.425237e-4 |
GO:2000461 | negative regulation of eukaryotic cell surface binding | 2.425237e-4 |
GO:0070994 | detection of oxidative stress | 2.425237e-4 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 2.436449e-4 |
GO:0015891 | siderophore transport | 2.560237e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 2.627478e-4 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 2.691304e-4 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.780556e-4 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 3.299873e-4 |
GO:0007021 | tubulin complex assembly | 3.310464e-4 |
GO:0048665 | neuron fate specification | 3.450996e-4 |
GO:0071108 | protein K48-linked deubiquitination | 3.642410e-4 |
GO:0009107 | lipoate biosynthetic process | 3.731547e-4 |
GO:0001830 | trophectodermal cell fate commitment | 3.731547e-4 |
GO:0006901 | vesicle coating | 3.789938e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 3.926502e-4 |
GO:0042254 | ribosome biogenesis | 4.051367e-4 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 4.126423e-4 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 4.177703e-4 |
GO:0002679 | respiratory burst involved in defense response | 4.596319e-4 |
GO:0070253 | somatostatin secretion | 5.073690e-4 |
GO:0032812 | positive regulation of epinephrine secretion | 5.073690e-4 |
GO:0044342 | type B pancreatic cell proliferation | 5.086520e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 5.086520e-4 |
GO:0050775 | positive regulation of dendrite morphogenesis | 5.665747e-4 |
GO:0030072 | peptide hormone secretion | 5.922403e-4 |
GO:0043308 | eosinophil degranulation | 6.121634e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 6.121634e-4 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 6.208318e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 6.297435e-4 |
GO:0035329 | hippo signaling cascade | 6.478902e-4 |
GO:0014812 | muscle cell migration | 6.677581e-4 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 6.795208e-4 |
GO:0010727 | negative regulation of hydrogen peroxide metabolic process | 6.795208e-4 |
GO:0048013 | ephrin receptor signaling pathway | 6.825635e-4 |
GO:0060023 | soft palate development | 6.890929e-4 |
GO:0021517 | ventral spinal cord development | 6.906382e-4 |
GO:0000387 | spliceosomal snRNP assembly | 7.007467e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 7.183523e-4 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 7.775245e-4 |
GO:0060298 | positive regulation of sarcomere organization | 7.775245e-4 |
GO:0072668 | tubulin complex biogenesis | 7.832955e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 7.848337e-4 |
GO:0042572 | retinol metabolic process | 8.099072e-4 |
GO:0018202 | peptidyl-histidine modification | 8.218867e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 8.279769e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 8.421444e-4 |
GO:0010871 | negative regulation of receptor biosynthetic process | 8.472322e-4 |
GO:0048484 | enteric nervous system development | 9.112244e-4 |
GO:0006900 | membrane budding | 9.513067e-4 |
GO:0060263 | regulation of respiratory burst | 9.599347e-4 |
GO:0006386 | termination of RNA polymerase III transcription | 9.735637e-4 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 9.735637e-4 |
GO:0071316 | cellular response to nicotine | 9.860035e-4 |
GO:0060297 | regulation of sarcomere organization | 9.886213e-4 |
GO:0032677 | regulation of interleukin-8 production | 9.907246e-4 |
GO:0071545 | inositol phosphate catabolic process | 9.941904e-4 |
GO:0009744 | response to sucrose stimulus | 1.018783e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 1.029476e-3 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 1.041685e-3 |
GO:0006278 | RNA-dependent DNA replication | 1.052226e-3 |
GO:0001659 | temperature homeostasis | 1.066175e-3 |
GO:0021511 | spinal cord patterning | 1.109197e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.142356e-3 |
GO:0046333 | octopamine metabolic process | 1.151238e-3 |
GO:0042309 | homoiothermy | 1.151238e-3 |
GO:0072592 | oxygen metabolic process | 1.203924e-3 |
GO:0015874 | norepinephrine transport | 1.203924e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.236471e-3 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.238879e-3 |
GO:0042424 | catecholamine catabolic process | 1.255678e-3 |
GO:0007029 | endoplasmic reticulum organization | 1.267950e-3 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 1.336983e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 1.337482e-3 |
GO:0051450 | myoblast proliferation | 1.355721e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 1.358292e-3 |
GO:0006261 | DNA-dependent DNA replication | 1.362435e-3 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 1.362562e-3 |
GO:0008628 | induction of apoptosis by hormones | 1.364568e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 1.394016e-3 |
GO:0070986 | left/right axis specification | 1.425368e-3 |
GO:0043084 | penile erection | 1.497606e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 1.538196e-3 |
GO:0015886 | heme transport | 1.540408e-3 |
GO:0001675 | acrosome assembly | 1.562654e-3 |
GO:0016198 | axon choice point recognition | 1.624449e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1.673759e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 1.673759e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 1.673759e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 1.673759e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 1.673759e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1.673759e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 1.673759e-3 |
GO:0002071 | glandular epithelial cell maturation | 1.673759e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.673759e-3 |
GO:0046619 | optic placode formation involved in camera-type eye formation | 1.677928e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.677928e-3 |
GO:0034227 | tRNA thio-modification | 1.677928e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.763738e-3 |
GO:0030011 | maintenance of cell polarity | 1.773606e-3 |
GO:0046511 | sphinganine biosynthetic process | 1.839795e-3 |
GO:0016601 | Rac protein signal transduction | 1.949432e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.985664e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 2.026621e-3 |
GO:0031427 | response to methotrexate | 2.026621e-3 |
GO:0048149 | behavioral response to ethanol | 2.058069e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 2.096678e-3 |
GO:0002790 | peptide secretion | 2.146658e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 2.214592e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 2.214592e-3 |
GO:0050884 | neuromuscular process controlling posture | 2.225449e-3 |
GO:0097039 | protein linear polyubiquitination | 2.288388e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 2.329256e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 2.528702e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.535846e-3 |
GO:0045910 | negative regulation of DNA recombination | 2.542923e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 2.570792e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 2.577267e-3 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 2.599603e-3 |
GO:0001824 | blastocyst development | 2.667665e-3 |
GO:0048677 | axon extension involved in regeneration | 2.817936e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 2.817936e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 2.817936e-3 |
GO:0002721 | regulation of B cell cytokine production | 2.817936e-3 |
GO:0015761 | mannose transport | 2.817936e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.817936e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.844280e-3 |
GO:0018095 | protein polyglutamylation | 2.860418e-3 |
GO:0044335 | canonical Wnt receptor signaling pathway involved in neural crest cell differentiation | 2.872248e-3 |
GO:0006448 | regulation of translational elongation | 2.967979e-3 |
GO:0035303 | regulation of dephosphorylation | 2.992943e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 3.114970e-3 |
GO:0090192 | regulation of glomerulus development | 3.142180e-3 |
GO:0051282 | regulation of sequestering of calcium ion | 3.162437e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 3.254613e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 3.364831e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 3.575416e-3 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 3.846183e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 3.853088e-3 |
GO:0008054 | cyclin catabolic process | 3.856032e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.874869e-3 |
GO:0046622 | positive regulation of organ growth | 3.932031e-3 |
GO:0072268 | pattern specification involved in metanephros development | 3.934235e-3 |
GO:0030910 | olfactory placode formation | 3.957608e-3 |
GO:0031468 | nuclear envelope reassembly | 4.162755e-3 |
GO:0051791 | medium-chain fatty acid metabolic process | 4.162755e-3 |
GO:0016561 | protein import into peroxisome matrix, translocation | 4.162755e-3 |
GO:0006542 | glutamine biosynthetic process | 4.300139e-3 |
GO:0045103 | intermediate filament-based process | 4.434248e-3 |
GO:0015833 | peptide transport | 4.528371e-3 |
GO:0019348 | dolichol metabolic process | 4.573745e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 4.581199e-3 |
GO:0019068 | virion assembly | 4.732549e-3 |
GO:0051793 | medium-chain fatty acid catabolic process | 4.732549e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 4.890054e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 4.890054e-3 |
GO:0035461 | vitamin transmembrane transport | 4.890054e-3 |
GO:0001736 | establishment of planar polarity | 5.133968e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 5.181415e-3 |
GO:0060214 | endocardium formation | 5.188256e-3 |
GO:0000117 | regulation of transcription involved in G2/M-phase of mitotic cell cycle | 5.188256e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 5.242064e-3 |
GO:0006778 | porphyrin-containing compound metabolic process | 5.249030e-3 |
GO:0051081 | nuclear envelope disassembly | 5.288556e-3 |
GO:0009437 | carnitine metabolic process | 5.644697e-3 |
GO:0003310 | pancreatic A cell differentiation | 5.644697e-3 |
GO:0070194 | synaptonemal complex disassembly | 5.679761e-3 |
GO:0060133 | somatotropin secreting cell development | 5.679761e-3 |
GO:0090251 | protein localization involved in establishment of planar polarity | 5.679761e-3 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 5.679761e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 5.679761e-3 |
GO:0001805 | positive regulation of type III hypersensitivity | 5.679761e-3 |
GO:0015961 | diadenosine polyphosphate catabolic process | 5.679761e-3 |
GO:0045218 | zonula adherens maintenance | 5.683515e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 5.683515e-3 |
GO:0051464 | positive regulation of cortisol secretion | 5.789502e-3 |
GO:0051725 | protein de-ADP-ribosylation | 5.789502e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.789502e-3 |
GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep | 5.789502e-3 |
GO:0033133 | positive regulation of glucokinase activity | 5.878533e-3 |
GO:0030382 | sperm mitochondrion organization | 5.878533e-3 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 6.357355e-3 |
GO:0046339 | diacylglycerol metabolic process | 6.376657e-3 |
GO:0016553 | base conversion or substitution editing | 6.785169e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 6.803777e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 6.803777e-3 |
GO:0006548 | histidine catabolic process | 6.823725e-3 |
GO:0060669 | embryonic placenta morphogenesis | 6.971478e-3 |
GO:0009062 | fatty acid catabolic process | 6.981782e-3 |
GO:0010921 | regulation of phosphatase activity | 7.058288e-3 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 7.267656e-3 |
GO:0048291 | isotype switching to IgG isotypes | 7.267656e-3 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 7.267656e-3 |
GO:0002368 | B cell cytokine production | 7.267656e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 7.284914e-3 |
GO:0061144 | alveolar secondary septum development | 7.284914e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 7.284914e-3 |
GO:0016598 | protein arginylation | 7.284914e-3 |
GO:0015878 | biotin transport | 7.284914e-3 |
GO:0015887 | pantothenate transmembrane transport | 7.284914e-3 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 7.284914e-3 |
GO:0008645 | hexose transport | 7.350252e-3 |
GO:0006667 | sphinganine metabolic process | 7.437516e-3 |
GO:0046931 | pore complex assembly | 7.455813e-3 |
GO:0015749 | monosaccharide transport | 7.842100e-3 |
GO:0007623 | circadian rhythm | 7.924172e-3 |
GO:0042168 | heme metabolic process | 7.930854e-3 |
GO:0051462 | regulation of cortisol secretion | 7.937444e-3 |
GO:0032765 | positive regulation of mast cell cytokine production | 7.937444e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 7.940707e-3 |
GO:0072015 | glomerular visceral epithelial cell development | 7.940707e-3 |
GO:0046718 | entry of virus into host cell | 7.984104e-3 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 7.993585e-3 |
GO:0043584 | nose development | 8.116009e-3 |
GO:0008105 | asymmetric protein localization | 8.227007e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 8.246753e-3 |
GO:0001743 | optic placode formation | 8.324645e-3 |
GO:0022616 | DNA strand elongation | 8.451434e-3 |
GO:0015876 | acetyl-CoA transport | 8.506080e-3 |
GO:0000027 | ribosomal large subunit assembly | 8.506080e-3 |
GO:0045576 | mast cell activation | 8.536914e-3 |
GO:0043266 | regulation of potassium ion transport | 8.598000e-3 |
GO:0006783 | heme biosynthetic process | 8.959621e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 9.006184e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 9.006184e-3 |
GO:0042273 | ribosomal large subunit biogenesis | 9.006883e-3 |
GO:0072329 | monocarboxylic acid catabolic process | 9.128895e-3 |
GO:0009106 | lipoate metabolic process | 9.208011e-3 |
GO:0032205 | negative regulation of telomere maintenance | 9.225188e-3 |
GO:0060384 | innervation | 9.269108e-3 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 9.301062e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 9.330780e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 9.438734e-3 |
GO:0048755 | branching morphogenesis of a nerve | 9.443883e-3 |
GO:0060449 | bud elongation involved in lung branching | 9.483627e-3 |
GO:0060662 | salivary gland cavitation | 9.865912e-3 |
GO:0033278 | cell proliferation in midbrain | 1.001239e-2 |
GO:0010994 | free ubiquitin chain polymerization | 1.001239e-2 |
GO:0048265 | response to pain | 1.014409e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.017658e-2 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 1.017658e-2 |
GO:0045064 | T-helper 2 cell differentiation | 1.017658e-2 |
GO:0002315 | marginal zone B cell differentiation | 1.017658e-2 |
GO:0033013 | tetrapyrrole metabolic process | 1.039457e-2 |
GO:0090042 | tubulin deacetylation | 1.046451e-2 |
GO:0070846 | Hsp90 deacetylation | 1.046451e-2 |
GO:0051182 | coenzyme transport | 1.061326e-2 |
GO:0007164 | establishment of tissue polarity | 1.071985e-2 |
GO:0050433 | regulation of catecholamine secretion | 1.090883e-2 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.119049e-2 |
GO:0019233 | sensory perception of pain | 1.122703e-2 |
GO:0072193 | ureter smooth muscle cell differentiation | 1.146256e-2 |
GO:0034346 | positive regulation of type III interferon production | 1.146256e-2 |
GO:0090219 | negative regulation of lipid kinase activity | 1.164792e-2 |
GO:0007443 | Malpighian tubule morphogenesis | 1.164792e-2 |
GO:0000917 | barrier septum formation | 1.164792e-2 |
GO:0001834 | trophectodermal cell proliferation | 1.185274e-2 |
GO:0060686 | negative regulation of prostatic bud formation | 1.192110e-2 |
GO:0042752 | regulation of circadian rhythm | 1.192945e-2 |
GO:0061004 | pattern specification involved in kidney development | 1.199916e-2 |
GO:0050690 | regulation of defense response to virus by virus | 1.202575e-2 |
GO:0072110 | glomerular mesangial cell proliferation | 1.206091e-2 |
GO:0045986 | negative regulation of smooth muscle contraction | 1.206091e-2 |
GO:0043045 | DNA methylation involved in embryo development | 1.206091e-2 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.211093e-2 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1.216383e-2 |
GO:0021510 | spinal cord development | 1.261875e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.268824e-2 |
GO:0060659 | nipple sheath formation | 1.284302e-2 |
GO:0060649 | mammary gland bud elongation | 1.284302e-2 |
GO:0032099 | negative regulation of appetite | 1.294138e-2 |
GO:0016556 | mRNA modification | 1.294138e-2 |
GO:0001829 | trophectodermal cell differentiation | 1.306764e-2 |
GO:0001835 | blastocyst hatching | 1.319167e-2 |
GO:0006342 | chromatin silencing | 1.335323e-2 |
GO:0060560 | developmental growth involved in morphogenesis | 1.338118e-2 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.390977e-2 |
GO:0010980 | positive regulation of vitamin D 24-hydroxylase activity | 1.390977e-2 |
GO:0007192 | activation of adenylate cyclase activity by serotonin receptor signaling pathway | 1.390977e-2 |
GO:0051764 | actin crosslink formation | 1.393862e-2 |
GO:0072104 | glomerular capillary formation | 1.432413e-2 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.433647e-2 |
GO:0070093 | negative regulation of glucagon secretion | 1.434316e-2 |
GO:0050666 | regulation of homocysteine metabolic process | 1.434316e-2 |
GO:0060087 | relaxation of vascular smooth muscle | 1.434918e-2 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 1.442063e-2 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.483956e-2 |
GO:0006482 | protein demethylation | 1.485383e-2 |
GO:0046434 | organophosphate catabolic process | 1.493570e-2 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 1.499275e-2 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.499354e-2 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.529276e-2 |
GO:0050975 | sensory perception of touch | 1.539492e-2 |
GO:0006382 | adenosine to inosine editing | 1.539492e-2 |
GO:0032757 | positive regulation of interleukin-8 production | 1.539606e-2 |
GO:0071539 | protein localization to centrosome | 1.572923e-2 |
GO:0072086 | specification of loop of Henle identity | 1.597717e-2 |
GO:0016525 | negative regulation of angiogenesis | 1.601348e-2 |
GO:0032910 | regulation of transforming growth factor beta3 production | 1.614518e-2 |
GO:0060695 | negative regulation of cholesterol transporter activity | 1.619362e-2 |
GO:0001812 | positive regulation of type I hypersensitivity | 1.619362e-2 |
GO:0033032 | regulation of myeloid cell apoptosis | 1.619920e-2 |
GO:0060596 | mammary placode formation | 1.636080e-2 |
GO:0046601 | positive regulation of centriole replication | 1.640000e-2 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 1.672866e-2 |
GO:0030260 | entry into host cell | 1.685063e-2 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.689957e-2 |
GO:0019730 | antimicrobial humoral response | 1.705552e-2 |
GO:0042312 | regulation of vasodilation | 1.717287e-2 |
GO:0051660 | establishment of centrosome localization | 1.740207e-2 |
GO:0021540 | corpus callosum morphogenesis | 1.740207e-2 |
GO:0045354 | regulation of interferon-alpha biosynthetic process | 1.746575e-2 |
GO:0015884 | folic acid transport | 1.746575e-2 |
GO:0014821 | phasic smooth muscle contraction | 1.747032e-2 |
GO:0015758 | glucose transport | 1.747349e-2 |
GO:0072133 | metanephric mesenchyme morphogenesis | 1.773175e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.775750e-2 |
GO:0070198 | protein localization to chromosome, telomeric region | 1.812292e-2 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.812292e-2 |
GO:0010225 | response to UV-C | 1.812292e-2 |
GO:0010869 | regulation of receptor biosynthetic process | 1.838689e-2 |
GO:0032096 | negative regulation of response to food | 1.851535e-2 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.857658e-2 |
GO:0043267 | negative regulation of potassium ion transport | 1.862577e-2 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.865033e-2 |
GO:0071415 | cellular response to purine-containing compound | 1.871363e-2 |
GO:0051013 | microtubule severing | 1.871363e-2 |
GO:0035810 | positive regulation of urine volume | 1.880576e-2 |
GO:0071217 | cellular response to external biotic stimulus | 1.894755e-2 |
GO:0072111 | cell proliferation involved in kidney development | 1.898594e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.902588e-2 |
GO:0009119 | ribonucleoside metabolic process | 1.905278e-2 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 1.911995e-2 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 2.005252e-2 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 2.022101e-2 |
GO:0031987 | locomotion involved in locomotory behavior | 2.022101e-2 |
GO:0009060 | aerobic respiration | 2.024472e-2 |
GO:0010976 | positive regulation of neuron projection development | 2.044909e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.076401e-2 |
GO:0034384 | high-density lipoprotein particle clearance | 2.078971e-2 |
GO:0035883 | enteroendocrine cell differentiation | 2.083756e-2 |
GO:0032597 | B cell receptor transport into membrane raft | 2.083756e-2 |
GO:0033345 | asparagine catabolic process via L-aspartate | 2.083756e-2 |
GO:0032913 | negative regulation of transforming growth factor beta3 production | 2.083756e-2 |
GO:0032600 | chemokine receptor transport out of membrane raft | 2.083756e-2 |
GO:0042117 | monocyte activation | 2.087703e-2 |
GO:0016090 | prenol metabolic process | 2.118240e-2 |
GO:0021522 | spinal cord motor neuron differentiation | 2.142423e-2 |
GO:0072195 | kidney smooth muscle cell differentiation | 2.147835e-2 |
GO:0072105 | ureteric peristalsis | 2.147835e-2 |
GO:0006498 | N-terminal protein lipidation | 2.147835e-2 |
GO:0001738 | morphogenesis of a polarized epithelium | 2.157635e-2 |
GO:0045905 | positive regulation of translational termination | 2.163879e-2 |
GO:0045901 | positive regulation of translational elongation | 2.163879e-2 |
GO:0006452 | translational frameshifting | 2.163879e-2 |
GO:0019067 | viral assembly, maturation, egress, and release | 2.168553e-2 |
GO:0072203 | cell proliferation involved in metanephros development | 2.199607e-2 |
GO:0051382 | kinetochore assembly | 2.204461e-2 |
GO:0051567 | histone H3-K9 methylation | 2.204461e-2 |
GO:0034470 | ncRNA processing | 2.229235e-2 |
GO:0021514 | ventral spinal cord interneuron differentiation | 2.230252e-2 |
GO:0019230 | proprioception | 2.233629e-2 |
GO:0060648 | mammary gland bud morphogenesis | 2.241305e-2 |
GO:0003157 | endocardium development | 2.261695e-2 |
GO:0010388 | cullin deneddylation | 2.309908e-2 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.310094e-2 |
GO:0035928 | rRNA import into mitochondrion | 2.341172e-2 |
GO:0006369 | termination of RNA polymerase II transcription | 2.385467e-2 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 2.398115e-2 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 2.398115e-2 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 2.402922e-2 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 2.402922e-2 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.409326e-2 |
GO:0042255 | ribosome assembly | 2.415837e-2 |
GO:0021535 | cell migration in hindbrain | 2.424325e-2 |
GO:2000296 | negative regulation of hydrogen peroxide catabolic process | 2.425992e-2 |
GO:0033342 | negative regulation of collagen binding | 2.425992e-2 |
GO:0045730 | respiratory burst | 2.439385e-2 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.449543e-2 |
GO:0060700 | regulation of ribonuclease activity | 2.449543e-2 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 2.449543e-2 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.449543e-2 |
GO:0048105 | establishment of body hair planar orientation | 2.449543e-2 |
GO:0046329 | negative regulation of JNK cascade | 2.464559e-2 |
GO:0051257 | spindle midzone assembly involved in meiosis | 2.466015e-2 |
GO:0007060 | male meiosis chromosome segregation | 2.466015e-2 |
GO:0035441 | cell migration involved in vasculogenesis | 2.489816e-2 |
GO:0034442 | regulation of lipoprotein oxidation | 2.489816e-2 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 2.489816e-2 |
GO:0046128 | purine ribonucleoside metabolic process | 2.490372e-2 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 2.496051e-2 |
GO:0010664 | negative regulation of striated muscle cell apoptosis | 2.503590e-2 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 2.523361e-2 |
GO:0072109 | glomerular mesangium development | 2.523361e-2 |
GO:0060572 | morphogenesis of an epithelial bud | 2.524514e-2 |
GO:0060155 | platelet dense granule organization | 2.529682e-2 |
GO:0046500 | S-adenosylmethionine metabolic process | 2.530536e-2 |
GO:0048935 | peripheral nervous system neuron development | 2.568676e-2 |
GO:0032780 | negative regulation of ATPase activity | 2.572762e-2 |
GO:0045176 | apical protein localization | 2.573634e-2 |
GO:0006364 | rRNA processing | 2.581434e-2 |
GO:0016575 | histone deacetylation | 2.602618e-2 |
GO:0072081 | specification of nephron tubule identity | 2.603375e-2 |
GO:0014909 | smooth muscle cell migration | 2.603375e-2 |
GO:0021986 | habenula development | 2.603375e-2 |
GO:0030073 | insulin secretion | 2.631902e-2 |
GO:0001984 | vasodilation of artery involved in baroreceptor response to increased systemic arterial blood pressure | 2.635443e-2 |
GO:0001954 | positive regulation of cell-matrix adhesion | 2.639852e-2 |
GO:0071312 | cellular response to alkaloid | 2.668718e-2 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.695306e-2 |
GO:0030816 | positive regulation of cAMP metabolic process | 2.710051e-2 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 2.715366e-2 |
GO:0021895 | cerebral cortex neuron differentiation | 2.721936e-2 |
GO:0018208 | peptidyl-proline modification | 2.728654e-2 |
GO:0007141 | male meiosis I | 2.734574e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.764854e-2 |
GO:0009253 | peptidoglycan catabolic process | 2.764854e-2 |
GO:0031284 | positive regulation of guanylate cyclase activity | 2.777167e-2 |
GO:0045175 | basal protein localization | 2.777167e-2 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.790949e-2 |
GO:0014826 | vein smooth muscle contraction | 2.790949e-2 |
GO:0048205 | COPI coating of Golgi vesicle | 2.790949e-2 |
GO:0051650 | establishment of vesicle localization | 2.815197e-2 |
GO:0060658 | nipple morphogenesis | 2.820540e-2 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 2.820540e-2 |
GO:0042420 | dopamine catabolic process | 2.841539e-2 |
GO:0042274 | ribosomal small subunit biogenesis | 2.849474e-2 |
GO:0046879 | hormone secretion | 2.857982e-2 |
GO:0006903 | vesicle targeting | 2.869793e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006178 | guanine salvage | 1.340433e-9 |
GO:0032264 | IMP salvage | 1.340433e-9 |
GO:0046038 | GMP catabolic process | 1.340433e-9 |
GO:0032263 | GMP salvage | 1.340433e-9 |
GO:0040034 | regulation of development, heterochronic | 8.213969e-9 |
GO:0048505 | regulation of timing of cell differentiation | 1.289568e-8 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.937664e-8 |
GO:0043252 | sodium-independent organic anion transport | 3.715944e-8 |
GO:0045964 | positive regulation of dopamine metabolic process | 5.634098e-8 |
GO:0021895 | cerebral cortex neuron differentiation | 1.573386e-7 |
GO:0031427 | response to methotrexate | 2.036187e-7 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 2.270348e-7 |
GO:0009060 | aerobic respiration | 5.095768e-7 |
GO:0043103 | hypoxanthine salvage | 6.689571e-7 |
GO:0006168 | adenine salvage | 6.689571e-7 |
GO:0032261 | purine nucleotide salvage | 6.689571e-7 |
GO:0006188 | IMP biosynthetic process | 9.860728e-7 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1.110247e-6 |
GO:0006099 | tricarboxylic acid cycle | 1.720093e-6 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.876824e-6 |
GO:0043973 | histone H3-K4 acetylation | 1.876824e-6 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.876824e-6 |
GO:0051642 | centrosome localization | 1.926702e-6 |
GO:0035815 | positive regulation of renal sodium excretion | 2.899887e-6 |
GO:0016558 | protein import into peroxisome matrix | 3.439925e-6 |
GO:0048245 | eosinophil chemotaxis | 4.213616e-6 |
GO:0042482 | positive regulation of odontogenesis | 6.321508e-6 |
GO:0046356 | acetyl-CoA catabolic process | 6.323901e-6 |
GO:0021794 | thalamus development | 9.521361e-6 |
GO:0043173 | nucleotide salvage | 1.289014e-5 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.332725e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.541942e-5 |
GO:0043096 | purine base salvage | 1.801970e-5 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 1.901095e-5 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.901095e-5 |
GO:0060319 | primitive erythrocyte differentiation | 2.114407e-5 |
GO:0006625 | protein targeting to peroxisome | 2.364377e-5 |
GO:0006177 | GMP biosynthetic process | 2.478655e-5 |
GO:0006408 | snRNA export from nucleus | 2.534261e-5 |
GO:0007625 | grooming behavior | 2.903679e-5 |
GO:0042703 | menstruation | 3.108640e-5 |
GO:0050928 | negative regulation of positive chemotaxis | 3.108640e-5 |
GO:0019101 | female somatic sex determination | 3.108640e-5 |
GO:0035813 | regulation of renal sodium excretion | 3.626229e-5 |
GO:0060271 | cilium morphogenesis | 3.822889e-5 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 4.475103e-5 |
GO:0021954 | central nervous system neuron development | 4.768719e-5 |
GO:0051187 | cofactor catabolic process | 5.163738e-5 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 5.821562e-5 |
GO:0003094 | glomerular filtration | 5.821562e-5 |
GO:0014057 | positive regulation of acetylcholine secretion | 6.659318e-5 |
GO:0009109 | coenzyme catabolic process | 6.887817e-5 |
GO:0018364 | peptidyl-glutamine methylation | 7.446860e-5 |
GO:0035026 | leading edge cell differentiation | 8.508613e-5 |
GO:0007616 | long-term memory | 8.640199e-5 |
GO:0009067 | aspartate family amino acid biosynthetic process | 9.678497e-5 |
GO:0006566 | threonine metabolic process | 9.978225e-5 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.180267e-4 |
GO:0071394 | cellular response to testosterone stimulus | 1.212563e-4 |
GO:0051126 | negative regulation of actin nucleation | 1.268146e-4 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.268146e-4 |
GO:0002551 | mast cell chemotaxis | 1.268146e-4 |
GO:0009088 | threonine biosynthetic process | 1.268146e-4 |
GO:0021764 | amygdala development | 1.268146e-4 |
GO:0009113 | purine base biosynthetic process | 1.314080e-4 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.520554e-4 |
GO:0045872 | positive regulation of rhodopsin gene expression | 1.520554e-4 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.520554e-4 |
GO:0002534 | cytokine production involved in inflammatory response | 1.520554e-4 |
GO:0034276 | kynurenic acid biosynthetic process | 1.520554e-4 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.520554e-4 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.520554e-4 |
GO:0001938 | positive regulation of endothelial cell proliferation | 1.554697e-4 |
GO:0051365 | cellular response to potassium ion starvation | 1.689707e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.689707e-4 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 1.689707e-4 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.689707e-4 |
GO:0051030 | snRNA transport | 1.795910e-4 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 1.795910e-4 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 1.795910e-4 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 1.795910e-4 |
GO:0044062 | regulation of excretion | 1.888864e-4 |
GO:0045665 | negative regulation of neuron differentiation | 1.923709e-4 |
GO:0007184 | SMAD protein import into nucleus | 1.992600e-4 |
GO:0016068 | type I hypersensitivity | 2.213873e-4 |
GO:0007031 | peroxisome organization | 2.260335e-4 |
GO:0002513 | tolerance induction to self antigen | 2.295643e-4 |
GO:0006419 | alanyl-tRNA aminoacylation | 2.307901e-4 |
GO:0009066 | aspartate family amino acid metabolic process | 2.373775e-4 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 2.514120e-4 |
GO:0007620 | copulation | 3.017836e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 3.095990e-4 |
GO:0060829 | negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 3.384693e-4 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 3.418169e-4 |
GO:0021885 | forebrain cell migration | 3.435429e-4 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 3.614192e-4 |
GO:0018158 | protein oxidation | 3.614192e-4 |
GO:0060137 | maternal process involved in parturition | 3.719660e-4 |
GO:0048733 | sebaceous gland development | 3.719660e-4 |
GO:0048144 | fibroblast proliferation | 4.086104e-4 |
GO:0006084 | acetyl-CoA metabolic process | 4.172306e-4 |
GO:0060215 | primitive hemopoiesis | 4.341247e-4 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 4.494432e-4 |
GO:0006166 | purine ribonucleoside salvage | 4.618334e-4 |
GO:0072268 | pattern specification involved in metanephros development | 4.662501e-4 |
GO:0071549 | cellular response to dexamethasone stimulus | 4.818737e-4 |
GO:0051567 | histone H3-K9 methylation | 4.823503e-4 |
GO:0006144 | purine base metabolic process | 4.976549e-4 |
GO:0018993 | somatic sex determination | 5.593369e-4 |
GO:0009912 | auditory receptor cell fate commitment | 5.611331e-4 |
GO:0032796 | uropod organization | 5.790095e-4 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 5.790095e-4 |
GO:0043248 | proteasome assembly | 5.856473e-4 |
GO:0021953 | central nervous system neuron differentiation | 5.942999e-4 |
GO:0006333 | chromatin assembly or disassembly | 6.137911e-4 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 6.458522e-4 |
GO:0000963 | mitochondrial RNA processing | 6.458522e-4 |
GO:0046599 | regulation of centriole replication | 6.696426e-4 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 6.817350e-4 |
GO:0071773 | cellular response to BMP stimulus | 6.955356e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 7.040311e-4 |
GO:0021952 | central nervous system projection neuron axonogenesis | 7.250869e-4 |
GO:0070684 | seminal clot liquefaction | 7.381337e-4 |
GO:0031497 | chromatin assembly | 7.574135e-4 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 7.990420e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 8.218604e-4 |
GO:0043084 | penile erection | 8.703929e-4 |
GO:0009957 | epidermal cell fate specification | 8.703929e-4 |
GO:0090231 | regulation of spindle checkpoint | 8.975100e-4 |
GO:0010824 | regulation of centrosome duplication | 9.302965e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 9.475406e-4 |
GO:0003326 | pancreatic A cell fate commitment | 9.475406e-4 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 9.482625e-4 |
GO:0030182 | neuron differentiation | 1.035715e-3 |
GO:0031022 | nuclear migration along microfilament | 1.054725e-3 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.066491e-3 |
GO:0042851 | L-alanine metabolic process | 1.109259e-3 |
GO:0060164 | regulation of timing of neuron differentiation | 1.116139e-3 |
GO:0002118 | aggressive behavior | 1.118848e-3 |
GO:0015746 | citrate transport | 1.184049e-3 |
GO:0035928 | rRNA import into mitochondrion | 1.239504e-3 |
GO:0010669 | epithelial structure maintenance | 1.282229e-3 |
GO:0021819 | layer formation in cerebral cortex | 1.313649e-3 |
GO:0014047 | glutamate secretion | 1.335524e-3 |
GO:0043094 | cellular metabolic compound salvage | 1.340865e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.341914e-3 |
GO:0022029 | telencephalon cell migration | 1.485186e-3 |
GO:0014824 | artery smooth muscle contraction | 1.516369e-3 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 1.615477e-3 |
GO:0048659 | smooth muscle cell proliferation | 1.647616e-3 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 1.647616e-3 |
GO:0032780 | negative regulation of ATPase activity | 1.647616e-3 |
GO:0070267 | oncosis | 1.764223e-3 |
GO:0051882 | mitochondrial depolarization | 1.765631e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.765631e-3 |
GO:0070899 | mitochondrial tRNA wobble uridine modification | 1.765631e-3 |
GO:0051684 | maintenance of Golgi location | 1.765631e-3 |
GO:0000966 | RNA 5'-end processing | 1.765631e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 1.765631e-3 |
GO:0042443 | phenylethylamine metabolic process | 1.765631e-3 |
GO:0043101 | purine-containing compound salvage | 1.784979e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 1.851098e-3 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.005408e-3 |
GO:0043932 | ossification involved in bone remodeling | 2.024162e-3 |
GO:0051414 | response to cortisol stimulus | 2.031268e-3 |
GO:0034770 | histone H4-K20 methylation | 2.066648e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 2.125037e-3 |
GO:0097084 | vascular smooth muscle cell development | 2.177639e-3 |
GO:0045066 | regulatory T cell differentiation | 2.177939e-3 |
GO:0003188 | heart valve formation | 2.212501e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 2.214226e-3 |
GO:0071422 | succinate transmembrane transport | 2.214226e-3 |
GO:0060968 | regulation of gene silencing | 2.228515e-3 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 2.382608e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 2.419023e-3 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 2.534336e-3 |
GO:0010025 | wax biosynthetic process | 2.534336e-3 |
GO:0071548 | response to dexamethasone stimulus | 2.596847e-3 |
GO:0018202 | peptidyl-histidine modification | 2.603028e-3 |
GO:0033566 | gamma-tubulin complex localization | 2.645843e-3 |
GO:0032185 | septin cytoskeleton organization | 2.645843e-3 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.760493e-3 |
GO:0007097 | nuclear migration | 2.885743e-3 |
GO:0021960 | anterior commissure morphogenesis | 2.885743e-3 |
GO:0042637 | catagen | 2.910731e-3 |
GO:0030237 | female sex determination | 2.921005e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 3.057682e-3 |
GO:0021795 | cerebral cortex cell migration | 3.083887e-3 |
GO:0021801 | cerebral cortex radial glia guided migration | 3.230996e-3 |
GO:0006653 | 1,2-diacyl-sn-glycero-3-phosphocholine metabolic process | 3.338878e-3 |
GO:0001712 | ectodermal cell fate commitment | 3.338878e-3 |
GO:0045090 | retroviral genome replication | 3.379207e-3 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 3.486633e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 3.549235e-3 |
GO:0003195 | tricuspid valve formation | 3.565316e-3 |
GO:0021799 | cerebral cortex radially oriented cell migration | 3.656397e-3 |
GO:0072078 | nephron tubule morphogenesis | 3.711738e-3 |
GO:0007224 | smoothened signaling pathway | 3.760337e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 3.788055e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3.799781e-3 |
GO:0042713 | sperm ejaculation | 3.836224e-3 |
GO:0042417 | dopamine metabolic process | 4.189206e-3 |
GO:0033240 | positive regulation of cellular amine metabolic process | 4.275587e-3 |
GO:0071243 | cellular response to arsenic-containing substance | 4.492547e-3 |
GO:0046037 | GMP metabolic process | 4.580260e-3 |
GO:0045637 | regulation of myeloid cell differentiation | 4.634429e-3 |
GO:0006603 | phosphocreatine metabolic process | 4.646857e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 4.695604e-3 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 4.902522e-3 |
GO:0046874 | quinolinate metabolic process | 5.138512e-3 |
GO:0035810 | positive regulation of urine volume | 5.165362e-3 |
GO:0072560 | type B pancreatic cell maturation | 5.223040e-3 |
GO:0051660 | establishment of centrosome localization | 5.223040e-3 |
GO:0021540 | corpus callosum morphogenesis | 5.223040e-3 |
GO:0031507 | heterochromatin formation | 5.490466e-3 |
GO:0048858 | cell projection morphogenesis | 5.545150e-3 |
GO:0016476 | regulation of embryonic cell shape | 5.576725e-3 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 5.659761e-3 |
GO:0032853 | positive regulation of Ran GTPase activity | 5.659761e-3 |
GO:0010996 | response to auditory stimulus | 5.659761e-3 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 5.704154e-3 |
GO:0006457 | protein folding | 5.944966e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 6.192259e-3 |
GO:0043487 | regulation of RNA stability | 6.192375e-3 |
GO:0060375 | regulation of mast cell differentiation | 6.436886e-3 |
GO:0090076 | relaxation of skeletal muscle | 6.507682e-3 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 6.507682e-3 |
GO:0046394 | carboxylic acid biosynthetic process | 6.611648e-3 |
GO:0043488 | regulation of mRNA stability | 6.646531e-3 |
GO:0045333 | cellular respiration | 6.653642e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 6.662994e-3 |
GO:0003192 | mitral valve formation | 6.662994e-3 |
GO:0070050 | neuron homeostasis | 6.799735e-3 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 6.980773e-3 |
GO:0070831 | basement membrane assembly | 6.980773e-3 |
GO:0046605 | regulation of centrosome cycle | 7.018425e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 7.018425e-3 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 7.271808e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 7.271808e-3 |
GO:0001973 | adenosine receptor signaling pathway | 7.271808e-3 |
GO:0006685 | sphingomyelin catabolic process | 7.403768e-3 |
GO:0000076 | DNA replication checkpoint | 7.403768e-3 |
GO:0003341 | cilium movement | 7.420359e-3 |
GO:0032990 | cell part morphogenesis | 7.456549e-3 |
GO:0016578 | histone deubiquitination | 7.499962e-3 |
GO:0045446 | endothelial cell differentiation | 7.686268e-3 |
GO:0071277 | cellular response to calcium ion | 7.782432e-3 |
GO:0014902 | myotube differentiation | 7.872823e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 7.985963e-3 |
GO:0045655 | regulation of monocyte differentiation | 8.204912e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 8.284019e-3 |
GO:0006108 | malate metabolic process | 8.284019e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 8.497723e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 8.510573e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 8.510573e-3 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 8.510573e-3 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 8.521138e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 8.637498e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 8.668106e-3 |
GO:0034776 | response to histamine | 8.668106e-3 |
GO:0006258 | UDP-glucose catabolic process | 8.668106e-3 |
GO:0090273 | regulation of somatostatin secretion | 8.960156e-3 |
GO:0003323 | type B pancreatic cell development | 9.003549e-3 |
GO:0003175 | tricuspid valve development | 9.003549e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 9.017170e-3 |
GO:0045046 | protein import into peroxisome membrane | 9.017170e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 9.017170e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 9.088673e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 9.088673e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 9.088673e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 9.088673e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 9.088673e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 9.088673e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 9.088673e-3 |
GO:0033572 | transferrin transport | 9.088673e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 9.088673e-3 |
GO:0046952 | ketone body catabolic process | 9.088673e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 9.088673e-3 |
GO:0050935 | iridophore differentiation | 9.177356e-3 |
GO:0048937 | lateral line nerve glial cell development | 9.177356e-3 |
GO:0021533 | cell differentiation in hindbrain | 9.182605e-3 |
GO:0048268 | clathrin coat assembly | 9.365267e-3 |
GO:0050918 | positive chemotaxis | 9.517991e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 9.630854e-3 |
GO:0071722 | detoxification of arsenic-containing substance | 9.630854e-3 |
GO:0071726 | cellular response to diacyl bacterial lipopeptide | 9.630854e-3 |
GO:0042496 | detection of diacyl bacterial lipopeptide | 9.630854e-3 |
GO:0071354 | cellular response to interleukin-6 | 9.920460e-3 |
GO:0071173 | spindle assembly checkpoint | 9.978262e-3 |
GO:0071108 | protein K48-linked deubiquitination | 9.978262e-3 |
GO:0006901 | vesicle coating | 1.013976e-2 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.048818e-2 |
GO:0051788 | response to misfolded protein | 1.063062e-2 |
GO:0050765 | negative regulation of phagocytosis | 1.063062e-2 |
GO:0060948 | cardiac vascular smooth muscle cell development | 1.067921e-2 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.067921e-2 |
GO:0019049 | evasion of host defenses by virus | 1.067921e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.085744e-2 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 1.085744e-2 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 1.085744e-2 |
GO:0006529 | asparagine biosynthetic process | 1.085744e-2 |
GO:0046856 | phosphatidylinositol dephosphorylation | 1.096165e-2 |
GO:0016226 | iron-sulfur cluster assembly | 1.096165e-2 |
GO:0000271 | polysaccharide biosynthetic process | 1.103017e-2 |
GO:0032354 | response to follicle-stimulating hormone stimulus | 1.103324e-2 |
GO:0009086 | methionine biosynthetic process | 1.155043e-2 |
GO:0030149 | sphingolipid catabolic process | 1.155203e-2 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 1.157136e-2 |
GO:0090245 | axis elongation involved in somitogenesis | 1.157136e-2 |
GO:0045646 | regulation of erythrocyte differentiation | 1.171237e-2 |
GO:0046112 | nucleobase biosynthetic process | 1.189510e-2 |
GO:0030219 | megakaryocyte differentiation | 1.189510e-2 |
GO:0051661 | maintenance of centrosome location | 1.244753e-2 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 1.244753e-2 |
GO:0090102 | cochlea development | 1.278350e-2 |
GO:0001845 | phagolysosome assembly | 1.293821e-2 |
GO:0021903 | rostrocaudal neural tube patterning | 1.299800e-2 |
GO:0045599 | negative regulation of fat cell differentiation | 1.304396e-2 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.308038e-2 |
GO:0032319 | regulation of Rho GTPase activity | 1.320225e-2 |
GO:0010522 | regulation of calcium ion transport into cytosol | 1.325509e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.338047e-2 |
GO:0016101 | diterpenoid metabolic process | 1.341627e-2 |
GO:0031365 | N-terminal protein amino acid modification | 1.357071e-2 |
GO:0006555 | methionine metabolic process | 1.357071e-2 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.360015e-2 |
GO:0090303 | positive regulation of wound healing | 1.418947e-2 |
GO:0046007 | negative regulation of activated T cell proliferation | 1.418947e-2 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 1.418947e-2 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 1.418947e-2 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 1.445047e-2 |
GO:0001830 | trophectodermal cell fate commitment | 1.445047e-2 |
GO:0006405 | RNA export from nucleus | 1.463742e-2 |
GO:0043519 | regulation of myosin II filament organization | 1.471259e-2 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 1.527225e-2 |
GO:0061181 | regulation of chondrocyte development | 1.527225e-2 |
GO:0021644 | vagus nerve morphogenesis | 1.527225e-2 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 1.527225e-2 |
GO:0003158 | endothelium development | 1.536198e-2 |
GO:0021564 | vagus nerve development | 1.549233e-2 |
GO:0006334 | nucleosome assembly | 1.575306e-2 |
GO:0051492 | regulation of stress fiber assembly | 1.584148e-2 |
GO:0033504 | floor plate development | 1.621485e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.621485e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.627133e-2 |
GO:0045023 | G0 to G1 transition | 1.702609e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.702609e-2 |
GO:0042492 | gamma-delta T cell differentiation | 1.702609e-2 |
GO:0014028 | notochord formation | 1.702609e-2 |
GO:0014819 | regulation of skeletal muscle contraction | 1.703037e-2 |
GO:0001702 | gastrulation with mouth forming second | 1.714848e-2 |
GO:0031577 | spindle checkpoint | 1.757370e-2 |
GO:0090277 | positive regulation of peptide hormone secretion | 1.762549e-2 |
GO:0021955 | central nervous system neuron axonogenesis | 1.767651e-2 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 1.774461e-2 |
GO:0045329 | carnitine biosynthetic process | 1.774461e-2 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.774461e-2 |
GO:0046520 | sphingoid biosynthetic process | 1.775522e-2 |
GO:0010171 | body morphogenesis | 1.782302e-2 |
GO:0046466 | membrane lipid catabolic process | 1.784226e-2 |
GO:0000097 | sulfur amino acid biosynthetic process | 1.786836e-2 |
GO:0070933 | histone H4 deacetylation | 1.794567e-2 |
GO:0007567 | parturition | 1.794567e-2 |
GO:0050779 | RNA destabilization | 1.843106e-2 |
GO:0048539 | bone marrow development | 1.843106e-2 |
GO:0060112 | generation of ovulation cycle rhythm | 1.852357e-2 |
GO:0060802 | epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification | 1.852357e-2 |
GO:0090010 | transforming growth factor beta receptor signaling pathway involved in primitive streak formation | 1.852357e-2 |
GO:0046683 | response to organophosphorus | 1.852357e-2 |
GO:0048327 | axial mesodermal cell fate specification | 1.852357e-2 |
GO:0016482 | cytoplasmic transport | 1.852357e-2 |
GO:0002085 | inhibition of neuroepithelial cell differentiation | 1.852357e-2 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.852357e-2 |
GO:0007518 | myoblast cell fate determination | 1.852357e-2 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 1.852357e-2 |
GO:0003171 | atrioventricular valve development | 1.952887e-2 |
GO:0010172 | embryonic body morphogenesis | 1.956626e-2 |
GO:0034968 | histone lysine methylation | 1.957765e-2 |
GO:0050919 | negative chemotaxis | 1.958984e-2 |
GO:0032970 | regulation of actin filament-based process | 1.961733e-2 |
GO:0016071 | mRNA metabolic process | 1.962901e-2 |
GO:0008053 | mitochondrial fusion | 1.965709e-2 |
GO:0001502 | cartilage condensation | 1.972282e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.973986e-2 |
GO:0035058 | nonmotile primary cilium assembly | 1.978238e-2 |
GO:0061333 | renal tubule morphogenesis | 1.982180e-2 |
GO:0006942 | regulation of striated muscle contraction | 2.040256e-2 |
GO:0048663 | neuron fate commitment | 2.073464e-2 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.074624e-2 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 2.074624e-2 |
GO:0006323 | DNA packaging | 2.080145e-2 |
GO:0032693 | negative regulation of interleukin-10 production | 2.084556e-2 |
GO:0006734 | NADH metabolic process | 2.087590e-2 |
GO:0035304 | regulation of protein dephosphorylation | 2.093770e-2 |
GO:0070723 | response to cholesterol | 2.104010e-2 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 2.128449e-2 |
GO:0031943 | regulation of glucocorticoid metabolic process | 2.128449e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 2.146924e-2 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.146924e-2 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.146924e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.146924e-2 |
GO:0009125 | nucleoside monophosphate catabolic process | 2.212539e-2 |
GO:0072282 | metanephric nephron tubule morphogenesis | 2.229060e-2 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.229060e-2 |
GO:0015881 | creatine transport | 2.241868e-2 |
GO:0015680 | intracellular copper ion transport | 2.241868e-2 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 2.265015e-2 |
GO:0002793 | positive regulation of peptide secretion | 2.286651e-2 |
GO:0035601 | protein deacylation | 2.319941e-2 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 2.336670e-2 |
GO:0045647 | negative regulation of erythrocyte differentiation | 2.377478e-2 |
GO:0001936 | regulation of endothelial cell proliferation | 2.390532e-2 |
GO:0070460 | thyroid-stimulating hormone secretion | 2.390656e-2 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 2.390656e-2 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 2.390656e-2 |
GO:0015827 | tryptophan transport | 2.390656e-2 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.414812e-2 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 2.432436e-2 |
GO:0021513 | spinal cord dorsal/ventral patterning | 2.554033e-2 |
GO:0018027 | peptidyl-lysine dimethylation | 2.588199e-2 |
GO:0006164 | purine nucleotide biosynthetic process | 2.612856e-2 |
GO:0048755 | branching morphogenesis of a nerve | 2.629678e-2 |
GO:0031536 | positive regulation of exit from mitosis | 2.629678e-2 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 2.663796e-2 |
GO:0061113 | pancreas morphogenesis | 2.663796e-2 |
GO:0003065 | positive regulation of heart rate by epinephrine | 2.663796e-2 |
GO:0009950 | dorsal/ventral axis specification | 2.668140e-2 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.693770e-2 |
GO:0030902 | hindbrain development | 2.704782e-2 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 2.736079e-2 |
GO:0060285 | ciliary cell motility | 2.736079e-2 |
GO:0002074 | extraocular skeletal muscle development | 2.736079e-2 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 2.742081e-2 |
GO:0046513 | ceramide biosynthetic process | 2.786074e-2 |
GO:0045793 | positive regulation of cell size | 2.819526e-2 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.850903e-2 |
GO:0001842 | neural fold formation | 2.850903e-2 |
GO:0001675 | acrosome assembly | 2.850903e-2 |
GO:0043922 | negative regulation by host of viral transcription | 2.869630e-2 |
GO:0048240 | sperm capacitation | 2.894297e-2 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 2.895035e-2 |
GO:0032925 | regulation of activin receptor signaling pathway | 2.904197e-2 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.919988e-2 |
GO:0046785 | microtubule polymerization | 2.934585e-2 |
GO:0006476 | protein deacetylation | 2.946778e-2 |
GO:0035499 | carnosine biosynthetic process | 2.969554e-2 |
GO:0051926 | negative regulation of calcium ion transport | 3.012389e-2 |
GO:0006450 | regulation of translational fidelity | 3.025651e-2 |
GO:0035307 | positive regulation of protein dephosphorylation | 3.044173e-2 |
GO:0032956 | regulation of actin cytoskeleton organization | 3.047606e-2 |
GO:0021535 | cell migration in hindbrain | 3.071215e-2 |
GO:0032897 | negative regulation of viral transcription | 3.094099e-2 |
GO:0042276 | error-prone translesion synthesis | 3.111622e-2 |
GO:0032277 | negative regulation of gonadotropin secretion | 3.111622e-2 |
GO:0032011 | ARF protein signal transduction | 3.111622e-2 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 3.111622e-2 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 3.113929e-2 |
GO:0006898 | receptor-mediated endocytosis | 3.169108e-2 |
GO:0003181 | atrioventricular valve morphogenesis | 3.169949e-2 |
GO:0034629 | cellular protein complex localization | 3.212887e-2 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 3.212887e-2 |
GO:0010458 | exit from mitosis | 3.212887e-2 |
GO:0035306 | positive regulation of dephosphorylation | 3.229953e-2 |
GO:0006670 | sphingosine metabolic process | 3.229953e-2 |
GO:0022900 | electron transport chain | 3.230654e-2 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 3.261783e-2 |
GO:0048708 | astrocyte differentiation | 3.262403e-2 |
GO:0007320 | insemination | 3.270791e-2 |
GO:0051646 | mitochondrion localization | 3.287112e-2 |
GO:0015671 | oxygen transport | 3.324168e-2 |
GO:0032318 | regulation of Ras GTPase activity | 3.331340e-2 |
GO:0006939 | smooth muscle contraction | 3.393021e-2 |
GO:0001975 | response to amphetamine | 3.409867e-2 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 3.417518e-2 |
GO:0060037 | pharyngeal system development | 3.436649e-2 |
GO:0045652 | regulation of megakaryocyte differentiation | 3.464167e-2 |
GO:0072086 | specification of loop of Henle identity | 3.513804e-2 |
GO:2000095 | regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 3.513804e-2 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.513804e-2 |
GO:0007099 | centriole replication | 3.513804e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 3.513804e-2 |
GO:0060434 | bronchus morphogenesis | 3.517898e-2 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 3.517898e-2 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 3.517898e-2 |
GO:0060014 | granulosa cell differentiation | 3.517898e-2 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 3.517898e-2 |
GO:2000078 | positive regulation of type B pancreatic cell development | 3.533490e-2 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 3.533490e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 3.533490e-2 |
GO:0035106 | operant conditioning | 3.565065e-2 |
GO:0007023 | post-chaperonin tubulin folding pathway | 3.565065e-2 |
GO:0048664 | neuron fate determination | 3.598115e-2 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 3.611746e-2 |
GO:0045607 | regulation of auditory receptor cell differentiation | 3.611746e-2 |
GO:0031623 | receptor internalization | 3.617878e-2 |
GO:0021984 | adenohypophysis development | 3.622680e-2 |
GO:0035914 | skeletal muscle cell differentiation | 3.664649e-2 |
GO:0002062 | chondrocyte differentiation | 3.699371e-2 |
GO:0060322 | head development | 3.713823e-2 |
GO:0051340 | regulation of ligase activity | 3.726279e-2 |